The contamination of valsartan and other sartans, Part 2: Untargeted screening reveals contamination with amides additionally to known nitrosamine impurities.
Scherf-Clavel, Oliver
The contamination of valsartan and other sartans, Part 2: Untargeted screening reveals contamination with amides additionally to known nitrosamine impurities. [electronic resource] - Journal of pharmaceutical and biomedical analysis Aug 2019 - 278-284 p. digital
Publication Type: Journal Article
1873-264X
10.1016/j.jpba.2019.04.035 doi
Amides--chemistry
Angiotensin II Type 1 Receptor Blockers
Chromatography, High Pressure Liquid--methods
Drug Contamination--prevention & control
Nitrosamines--chemistry
Tandem Mass Spectrometry--methods
Valsartan--chemistry
The contamination of valsartan and other sartans, Part 2: Untargeted screening reveals contamination with amides additionally to known nitrosamine impurities. [electronic resource] - Journal of pharmaceutical and biomedical analysis Aug 2019 - 278-284 p. digital
Publication Type: Journal Article
1873-264X
10.1016/j.jpba.2019.04.035 doi
Amides--chemistry
Angiotensin II Type 1 Receptor Blockers
Chromatography, High Pressure Liquid--methods
Drug Contamination--prevention & control
Nitrosamines--chemistry
Tandem Mass Spectrometry--methods
Valsartan--chemistry